Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension

View source ↗

Summary

A clinical trial assessed the safety and efficacy of treprostinil to facilitate liver transplantation in patients with portopulmonary hypertension. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Portopulmonary Hypertension, Pulmonary Arterial Hypertension | Status: COMPLETED | Results posted: 2017-02-24